Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Heart valve – Flexible leaflet
Reexamination Certificate
1999-06-11
2001-12-11
Milano, Michael J. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Heart valve
Flexible leaflet
C623S002130, C623S002190, C623S002420
Reexamination Certificate
active
06328763
ABSTRACT:
FIELD OF THE INVENTION
This invention relates generally to a new and improved heart valve tissue pattern and heart valve for semilunar heart valve reconstruction.
BACKGROUND OF THE INVENTION
For nearly forty years, since the advent of the heart-lung machine, it has been possible to reconstruct and replace heart valves.
The concept of repairing, rather than replacing, diseased heart valves began with the work of Professor Ake Senning of Zurich in 1960. (Senning A:Fascia lata replacement of aortic valves.
Journal of Thoracic Cardiovascular Surgery
54:465-470 (1967)). Senning used autologous fascia lata to fashion three-dimensional aortic valve repairs with a freehand technique, but subsequently abandoned his method by 1970 because of valve failures from thickening and shrinkage of the fresh, untreated tissue. Because of the experiences of Senning and others using similar techniques to repair or reconstruct heart valves with fresh autologous tissue, focus in the field of heart valve disease shifted from valve repair and reconstruction to full valve replacement with mechanical prostheses, and later, with bioprostheses made from heterograft (animal) tissue supported by a plastic or metal stent or frame.
Mechanical valves, such as the St. Jude Mechanical Bileaflet Valve, are often preferred because they have indefinite durability. Mechanical valves, however, also have inherent disadvantages, such as, for example, the danger of inducing blood clotting, thus requiring most patients to be on life-long anticoagulation medication. Mechanical valves also have less than ideal hemodynamic (blood flow) properties, they can be noisy, and the structural failures associated with such valves are usually catastrophic. Additional disadvantages are well known to those skilled in the art.
Heterograft (animal) tissue valves typically employ a semi-rigid frame, or stent, which supports animal tissue leaflets. Such stents are attached to the patient's heart with sutures. Tissue valves were originally believed to provide answers to most of the problems associated with mechanical valves: they significantly reduce the need for anticoagulation therapy, they have better, though not ideal, hemodynamic qualities, they are quiet, and their failure modes are generally slower, allowing time for surgical intervention to replace a failing valve. Clinical experience, however, has shown that such tissue valves have limited durability, for example, on the order of five to fifteen years. This limited durability is usually due to calcium build up on the foreign tissue, known as calcific degeneration, and is thought by several investigators to be caused by an immune response to the presence of a foreign tissue. There are also inherent disadvantages to using such frames, or stents, such as, for example, the space the stent occupies in the annular area thereby reducing effective valve orifice area, and possible abrasion of the tissue against the stent thereby causing or contributing to primary tissue failure of the valve.
Beginning in 1985, Love suggested using autologous pericardium, treated with a brief immersion in a glutaraldehyde solution, for use in an autologous tissue replacement for heart valves (Love et al. “Rapid intraoperative fabrication of an autogenous tissue heart valve: A new technique.”
Proceedings of the Third International Symposium on Cardiac Bioprostheses
691-698 (1986)). Later, Love reported that autologous pericardium, briefly treated in glutaraldehyde, does not thicken or shrink, is resistant to calcific degeneration, and is durable beyond 25 equivalent years in the accelerated life tester. (Love et al. Experimental evaluation of an autologous tissue heart valve.
Journal of Heart Valve Disease
, 1992; 1232-241). Others, such as Carpentier, a physician working on problems with the mitral valve, showed similar results (Chauvaud et al. “Valve extension with glutaraldehyde-preserved autologous pericardium”
Journal of Thoracic and Cardiovascular Surgery
102:171-178 (1991)). Duran, another physician, resurrected Senning's techniques, and has used autologous pericardium treated with a brief immersion in glutaraldehyde for repair of diseased aortic valves, with good results, including lack of calcification. (Duran et al. “Indications and limitations of aortic valve reconstruction”
Annals of Thoracic Surgery
52:447-454 (1991)).
In spite of the discovery that glutaraldehyde-treated autologous tissue, as opposed to fresh, untreated tissue, can be used as a material for heart valve replacement or repair, significant problems still exist with all of the reported approaches for repairing and reconstructing heart valves including, but not limited to, semilunar heart valves. These problems include, for example, that they are not standardized and they do not employ a relatively precise, pre-designed, reproducible, optimized pattern of two-dimensional tissue which, when attached to the aortic annulus and pressure loaded at physiologic levels, achieves normal or near normal three-dimensional anatomy when used to function as a semilunar heart valve.
In order to overcome the disadvantages of the prior art, as those skilled in the art will recognize and appreciate, there is an established need for an improved, more easily reproducible, less complicated, generally standardized, design and method of making a unitary valve tissue pattern to be used for the repair or reconstruction of a semilunar heart valve, having a generally simulated anatomical shape and good blood flow characteristics. The claimed invention provides a new, useful and unique two-dimensional valve tissue pattern design and method which may be used for easily fabricating three-dimensional heart valves for heart valve repair or reconstruction, which overcome many of the disadvantages of the prior art.
BRIEF SUMMARY OF THE INVENTION
The subject invention teaches a new and unique, optimized, two-dimensional heart valve tissue pattern, and a method of reconstructing a three-dimensional semilunar heart valve, or portion thereof, which pattern and valve are more efficient, more easily reproduced, less complicated to fabricate, and have enhanced performance characteristics.
In one preferred embodiment of the present invention, the improved two-dimensional valve tissue pattern of the present invention, prior to being affixed to a heart (and oriented into a three-dimensional valve, or a portion thereof), comprises a two-dimensional configuration that delimits a two dimensional area that corresponds to the shape of tissue to be used in the repair of at least one leaflet of a circulatory system semilunar valve, wherein the configuration delimits at least one segment, and up to all three segments, of a three segment “trefoil” shape. The anatomy of semilunar cardiac outflow valves typically have an essentially symmetrical tri-leaflet geometry with leaflet support provided by the scalloped annular attachment and the fixed length of the leaflet free edges extending from the commissures. The unique two-dimensional trefoil tissue pattern of the present invention can be made from any appropriate materials such as, for example, autologous tissue (including, for example, pericardium, facia lata and rectus sheath). Additional acceptable materials include heterograft (bovine, porcine, or other animal tissue) pericardium, synthetic materials, bioengineered materials, or any other like or suitable materials having appropriate plasticity and characteristics, as will be appreciated by those skilled in the art. In the preferred embodiment, autologous lightly tanned pericardium is used for the trefoil tissue pattern.
In one preferred embodiment, the valve tissue pattern is preferably created by cutting, shaping, or otherwise forming, essentially, a triangle, preferably equilateral in one embodiment, shaped orifice having linear or, in some alternative embodiments, non-linear sides such as, for example, concave sides, preferably in the center of a tissue pattern. The perimeter of the tissue pattern is preferably cut, shaped or otherwise formed into a pattern such
Hanlon James G.
Love Jack W.
Suggitt Robert W.
Bryan Cave LLP
CardioMend LLC
Milano Michael J.
LandOfFree
Optimized geometry of a tissue pattern for semilunar heart... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optimized geometry of a tissue pattern for semilunar heart..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optimized geometry of a tissue pattern for semilunar heart... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2583220